The UK’s leading pharmaceutical companies, GSK and Astrazeneca ... of developing their own research pipeline and then buying and selling smaller companies or development candidates from their ...

AstraZeneca and its global biologics research and development arm MedImmune will demonstrate the latest findings at the European Society of Cardiology (ESC) Congress in Munich, Germany ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

AstraZeneca has revealed it has expanded ... The changes include the creation of: • Three senior research and development roles responsible for discovery and early stage development in small ...

VIB and CD3 (KU Leuven) today announced the signing of a license and collaboration agreement with AstraZeneca for the development of novel MALT1 inhibitors as therapeutics in inflammatory and ...

In 2023, AstraZeneca contributed more than CA$230 million in research and development in Candana, much of which was focused on delivering over 210 AstraZeneca global clinical studies of new ...